Professor David Paterson is CEO of Wesley Medical Research and Professor of Infectious Diseases at the University of Queensland.
Professor Paterson grew up in Brisbane and then then worked for a decade in the United States and Italy before returning to Australia in 2007. His twin passions are killing bacteria and caring for patients with bacterial infections. He has contributed to guidelines for antibiotic use for the Infectious Diseases Society of America and he has lectured in 30 countries worldwide on the topic of bacterial resistance to antibiotics.
- Anticoagulation strategies in non–critically ill patients with Covid-19
- Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: A structured, narrative review
- Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials